Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Vasopressin and Inhaled Prostacyclin in Pediatric Pulmonary Hypertension

This study has been terminated.
(Difficulty with patient recruitment)
Information provided by (Responsible Party):
Lindsay Ryerson, University of Alberta Identifier:
First received: June 8, 2011
Last updated: October 24, 2016
Last verified: September 2016
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: September 2016
  Primary Completion Date: September 2016 (Final data collection date for primary outcome measure)